Edgewise Therapeutics, Inc.
USD37.25
-3.01 (-7.48%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$39.95
Prev. Close
$40.26
Day Low
$37.02
Day High
$40.04
52W Low
$12.15
52W High
$40.77
Market Cap
$4.01B
Volume
2.37M
| 50,000 |
| $7.08 |
| 5 May 2026 | Donovan Joanne M. | CMO | S-Sale | Disposed | 50,000 | $38.57 |
| 5 May 2026 | Donovan Joanne M. | CMO | M-Exempt | Disposed | 50,000 | $7.08 |
| 3 Apr 2026 | Fox Jonathan C | director | A-Award | Acquired | 339 | $0.00 |
| 2 Apr 2026 | Donovan Joanne M. | CMO | M-Exempt | Acquired | 28,662 | $7.08 |
| 2 Apr 2026 | Donovan Joanne M. | CMO | S-Sale | Disposed | 28,662 | $32.31 |
| 2 Apr 2026 | Donovan Joanne M. | CMO | M-Exempt | Disposed | 28,662 | $7.08 |
| 31 Mar 2026 | Donovan Joanne M. | CMO | M-Exempt | Acquired | 21,338 | $7.08 |
| 31 Mar 2026 | Donovan Joanne M. | CMO | S-Sale | Disposed | 21,338 | $32.12 |